Randgold (GOLD) (ABT) (UTHR) (BHE) (SANM) (BSX) Downgraded

Randgold Resources Ltd. (NASDAQ: GOLD), Abbott Laboratories (NYSE: ABT), United Therapeutics (NASDAQ: UTHR), Benchmark Electronics, Inc. (NYSE: BHE), Sanmina-SCI Co. (NASDAQ: SANM) and Boston Scientific (NYSE: BSX) downgraded by analysts.

Randgold Resources Ltd. (GOLD) was downgraded by RBC Capital from an “Outperform” rating to a “Sector Perform” rating.

Abbott Laboratories (ABT) was downgraded by Morgan Keegan from an “Outperform” rating to a “Market Perform” rating. They have a price target of $57.00 on the company, down from $60.00.

United Therapeutics (UTHR) was downgraded by JPMorgan Chase & Co. (NYSE:JPM) from an “Overweight” rating to a “Neutral” rating.

Benchmark Electronics, Inc. (BHE) was downgraded by RBC Capital from an “Outperform” rating to a “Sector Perform” rating. They have a price target of $13.00 on the company, down from $20.00.

Sanmina-SCI Co. (SANM) was downgraded by RBC Capital from a “Sector Perform” rating to an “Underperform” rating. They have a price target $5.00 on the company, down from $12.00.

Boston Scientific (BSX) was downgraded by Morgan Keegan from an “Outperform” rating to a “Market Perform” rating. They have a price target of $7.00 on the company, down from $8.00.

Ratings on (NVE) OMN) (RBN) (SANM) Get Analyst Upgrades

NV Energy (NYSE: NVE), OMNOVA Solutions Inc. (NYSE: OMN), Robbins & Myers (NYSE: RBN) and Sanmina-SCI Co. (NASDAQ: SANM) get upgrades today from analysts.

Soleil Securities upgraded NV Energy (NVE) from a “hold” rating to a “buy” rating. They have a price target of $17.00 on the company.

Jefferies (NYSE:JEF) upgraded OMNOVA Solutions Inc. (OMN) from a “hold” rating to a “buy” rating. They have a price target of $11.00 on the company, up from $8.25.

Global Hunter Securities upgraded shares of Robbins & Myers (RBN) from an “accumulate” rating to a “buy” rating. They have a price target of $54.00 on the company, up from $52.00.

Argus upgraded Sanmina-SCI Co. (SANM) from a “hold” rating to a “buy” rating. They have a price target of $15.00 on the company.

Sanmina-SCI (NASDAQ:SANM) Growth Driven by Multiple Catalysts

Sanmina-SCI (NASDAQ:SANM) is poised to enjoy strong growth in 2011, based on a pipeline of catalysts in a number of company segments.

Needham says, "Overall, Sanmina continues to be well positioned to demonstrate solid growth this year through a healthy pipeline of new wins in spaces such as Medical, Communications, Enterprise Computing & Storage and further aided by the acquisition of BreconRidge. We believe the company is executing well on and improved cost structure, and we further remain of the opinion that volume returning to components (in 2HF11) should drive healthy leverage and earnings growth in the model.

"Only minor changes to estimates. F2Q11 becomes $1.645B in revs. and $0.41. vs, prior $1.650B and $0.41. F11 now $6.86B and $1.86, vs. previous $6.86B & $1.83."

Needham & Company reiterates a "Buy" rating on Sanmina-SCI Corp. (SANM), which closed Tuesday at $14.77, gaining $0.70, or 4.98 percent. Needham has a price target on Sanmina-SCI of $19.